← Back
Data updated: Mar 29, 2026
NOVUGEN
Oncology
Generics
NOVUGEN is a generic drug manufacturer focused on Oncology.
2022
Since
5
Drugs
-
Trials
33
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
3 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Discontinued (1)
Company Info
- First Approval
- 2022-01-05
- Latest
- 2025-10-30
- Applications
- 5